Tango Therapeutics Inc.

Tango Therapeutics Inc.

World Rank (Jan-05-2024)
8,692
Market Cap (Jan-05-2024)
0.981 Billion USD
World Rank (Jul-30-2023)
16,442
Market Cap (Jul-30-2023)
0.270 Billion USD
World Rank (Jan-07-2022)
10,643
Market Cap (Jan-07-2022)
0.799 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
TNGX
Market Cap (Mar-08-2026)
2.28
Employee Count
91
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
37 Million USD
Annual Net Income in USD
-58 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
500 Million USD
Total Liabilities in USD
155 Million USD
Total Equity in USD
344 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Company Website
TANGO THERAPEUTICS, INC.
Company Profile

Tango Therapeutics is a Biotechnology company with the genetic alterations that fuel cancer by inactivating tumour suppressor genes and helping cancer cells evade killing by the immune system. The headquarters is in USA.

IPO Year
2020
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share